Albert David Limited (BOM:524075)
642.00
-37.15 (-5.47%)
At close: Mar 9, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 3.77 billion as of March 10, 2026. Its market cap has decreased by -27.24% in one year.
Market Cap
3.77B
Enterprise Value
1.34B
Revenue
3.23B
Ranking
n/a
PE Ratio
39.19
Stock Price
642.00
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 3.77B, an increase of 4,580.85%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.66B | -13.24% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 5.57B |
| Jenburkt Pharmaceuticals | 4.41B |
| Medicamen Biotech | 3.71B |
| Amanta Healthcare | 3.46B |
| Medico Remedies | 3.46B |
| ZIM Laboratories | 3.26B |
| Trident Lifeline | 3.20B |
| Everest Organics | 2.97B |